Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Juniper Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

13 May 2016 Reuters Investment Profile 12 $20.00

JNP: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

20 May 2016 New Constructs, LLC 10 $25.00

Thomson Reuters Stock Report - Juniper Pharmaceuticals Inc (JNP-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

19 May 2016 Thomson Reuters Stock Report 12 $25.00

Wright Investors Service Comprehensive Report for Juniper Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 May 2016 Wright Reports 56 $75.00

ValuEngine Rating and Forecast Report for JNP

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

15 May 2016 ValuEngine, Inc. 11 $25.00

Juniper Pharmaceuticals

14 May 2016 S&P Capital IQ Quantitative Report 10 $115.00

JUNIPER PHARMACEUTICALS INC (JNP=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

14 May 2016 Pechala's Reports 2 $25.00

Value Graph: JUNIPER PHARMA -- JNP

13 May 2016 Ford Investor Services, Inc. 1 $12.00

Juniper Pharmaceuticals, Inc. (JNP) - Financial and Strategic SWOT Analysis Review

Juniper Pharmaceuticals, Inc. (JNP) - Financial and Strategic SWOT Analysis Review Summary Juniper Pharmaceuticals, Inc. (Jun...

06 May 2016 GlobalData 69 $300.00

Juniper Pharmaceuticals Inc: Upgraded to Above Average

11 Apr 2016 Sadif Analytics Prime 3 $10.00